Morbidity and risk of subsequent diagnosis of HIV: A population based case control study identifying indicator diseases for HIV infection

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Søgaard, Ole S ^a   Lohse, Nicolai ^a   Østergaard, Lars ^a   Kronborg, Gitte ^b   Røge, Birgit ^c   Gerstoft, Jan ^d   Sørensen, Henrik T ^a,e   Obel, Niels ^d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c KOLDING HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANDIDIASIS; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENDOCARDITIS; FEMALE; HEMATOLOGIC DISEASE; HEPATITIS A; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; SCREENING TEST; SEXUALLY TRANSMITTED DISEASE; SKIN INFECTION; SUBSTANCE ABUSE; SYPHILIS; THROMBOCYTOPENIA; VIRUS DIAGNOSIS; VIRUS HEPATITIS; VIRUS TRANSMISSION; CASE CONTROL STUDY; DENMARK; HOSPITAL; MIDDLE AGED; RISK; TIME;

CANDIDA; HERPES ZOSTER; NON-A, NON-B HEPATITIS VIRUS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DENMARK; FEMALE; HIV INFECTIONS; HOSPITALS; HUMANS; MALE; MIDDLE AGED; RISK; TIME FACTORS; YOUNG ADULT;

EID: 84857750863     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032538     Document Type: Article

References (40)

1. Hall HI, Song R, Rhodes P, Prejean J, An Q, et al. (2008) Estimation of HIV incidence in the United States. JAMA 300: 520-529.
2. Coenen T, Lundgren J, Lazarus JV, Matic S, (2008) Optimal HIV testing and earlier care: the way forward in Europe. HIV Med 9 (Suppl 2): 1-5.
3. Chadborn TR, Delpech VC, Sabin CA, Sinka K, Evans BG, (2006) The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000-2004). AIDS 20: 2371-2379.
4. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, et al. (2010) Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 375: 2092-2098.
5. Montaner JS, Lima VD, Barrios R, Yip B, Wood E, et al. (2010) Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 376: 532-539.
6. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 342: 921-929.
7. Prevention ECfDCa (2010) HIV testing: increasing uptake and effectiveness in the European Union.: ECDC.
8. Marks G, Crepaz N, Janssen RS, (2006) Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 20: 1447-1450.
9. Montaner JS, Hogg R, Wood E, Kerr T, Tyndall M, et al. (2006) The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 368: 531-536.
10. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, et al. (2006) Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 55: 1-17; quiz CE11-14.
11. Paltiel AD, Weinstein MC, Kimmel AD, Seage GR, Losina E, et al. (2005) Expanded screening for HIV in the United States- An analysis of cost-effectiveness. N Engl J Medicine 352: 586-595.
12. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, et al. (2010) HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 375: 1014-1028.
13. Mounier-Jack S, Nielsen S, Coker RJ, (2008) HIV testing strategies across European countries. HIV Med 9 (Suppl 2): 13-19.
14. Burns FM, Johnson AM, Nazroo J, Ainsworth J, Anderson J, et al. (2008) Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. AIDS 22: 115-122.
15. Gazzard B, Clumeck N, d'Arminio Monforte A, Lundgren JD, (2008) Indicator disease-guided testing for HIV-the next step for Europe? HIV Med 9 (Suppl 2): 34-40.
16. Bini EJ, Currie SL, Shen H, Brau N, Schmidt W, et al. (2006) National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection. J Clin Gastroenterol 40: 732-739.
17. Bottieau E, Clerinx J, Van den Enden E, Van Esbroeck M, Colebunders R, et al. (2006) Infectious mononucleosis-like syndromes in febrile travelers returning from the tropics. J Travel Med 13: 191-197.
18. Klein D, Hurley LB, Merrill D, Quesenberry CP Jr, (2003) Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr 32: 143-152.
19. Noskin GA, Glassroth J, (1996) Bacterial pneumonia associated with HIV-1 infection. Clin Chest Med 17: 713-723.
20. Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, et al. (2008) Cohort Profile: The Danish HIV Cohort Study. Int J Epidemiol.
21. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB, (2006) The Danish Civil Registration System. A cohort of eight million persons. Danish med bulletin 53: 441-449.
22. Nickelsen TN, (2001) Data validity and coverage in the Danish National Health Registry. A literature review. Ugeskrift for laeger 164: 33-37.
23. Olsen JH, Andersen A, Dreyer L, Pukkala E, Tryggvadottir L, et al. (1997) Summary of avoidable cancers in the Nordic countries. APMIS Suppl 76: 141-146.
24. Richardson DB, (2004) An incidence density sampling program for nested case-control analyses. Occup Environ Med 61: e59.
25. No authors listed (1992) 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41: 1-19.
26. Chiao EY, Dezube BJ, Krown SE, Wachsman W, Brock MV, et al. (2010) Time for oncologists to opt in for routine opt-out HIV testing? JAMA 304: 334-339.
27. Sogaard OS, Lohse N, Gerstoft J, Kronborg G, Ostergaard L, et al. (2008) Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study. Clin Infect Dis 47: 1345-1353.
28. Mazick A, Howitz M, Rex S, Jensen IP, Weis N, et al. (2005) Hepatitis A outbreak among MSM linked to casual sex and gay saunas in Copenhagen, Denmark. Euro Surveill 10: 111-114.
29. Lindau ST, Gavrilova N, (2010) Sex, health, and years of sexually active life gained due to good health: evidence from two US population based cross sectional surveys of ageing. BMJ 340: c810.
30. Paltiel AD, Walensky RP, Schackman BR, Seage GR, Mercincavage LM, et al. (2006) Expanded HIV screening in the United States: Effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med 145: 797-806.
31. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, et al. (2005) Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 352: 570-585.
32. Haukoos JS, Hopkins E, Byyny RL, (2008) Patient acceptance of rapid HIV testing practices in an urban emergency department: assessment of the 2006 CDC recommendations for HIV screening in health care settings. Ann Emerg Med 51: 303-309, 309 e301.
33. Brown J, Shesser R, Simon G, Bahn M, Czarnogorski M, et al. (2007) Routine HIV screening in the emergency department using the new US Centers for Disease Control and Prevention Guidelines: results from a high-prevalence area. J Acquir Immune Defic Syndr 46: 395-401.
34. Kendrick SR, Kroc KA, Couture E, Weinstein RA, (2004) Comparison of point-of-care rapid HIV testing in three clinical venues. AIDS 18: 2208-2210.
35. Haukoos JS, Hopkins E, Conroy AA, Silverman M, Byyny RL, et al. (2010) Routine opt-out rapid HIV screening and detection of HIV infection in emergency department patients. JAMA 304: 284-292.
36. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG, (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48-57.
37. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, et al. (2009) Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival. N Engl J Med.
38. Wood E, Kerr T, Marshall BD, Li K, Zhang R, et al. (2009) Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ 338: b1649.
39. de la Fuente L, Delgado J, Hoyos J, Belza MJ, Alvarez J, et al. (2009) Increasing early diagnosis of HIV through rapid testing in a street outreach program in Spain. AIDS Patient Care STDS 23: 625-629.
40. Wolfe D, Carrieri MP, Shepard D, (2010) Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet 376: 355-366.